Lemaitre Vascular Inc chart

Last update: 2022-12-30
Key statistics and financials
Revenue per share 7.30
Dividend & Yield0.50$ (1.12%)
Beta 1.02
Market capitalization 995.1M
Operating cash flow 26.36M
ESG Scores unknown

Company description

LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system. The company also provides carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; and radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient's body, and allows them to locate tributaries or lesions beneath the skin. In addition, it offers valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and vascular grafts to bypass or replace diseased arteries. Further, the company provides vascular and cardiac patches, which are used for closure of vessels after surgical intervention; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.

Sector: Healthcare - Industry: Medical Instruments & Supplies

Financial data

Financial Statements

Cashflow Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Change To Liabilities 4.31M -596k 4.32M -1.73M
Total Cashflows From Investing Activities -7.05M -24.1M -52.89M -61.08M
Net Borrowings 39M 39M 39M -39M
Total Cash From Financing Activities -4.42M -4.62M 32.16M 13.7M
Change To Operating Activities -418k -654k 89k -1.93M
Issuance Of Stock 2.97M 4.86M 5.97M 63.24M
Net Income 22.94M 17.93M 21.22M 26.91M
Change In Cash 7.22M -14.53M 14.98M -12.91M
Effect Of Exchange Rate -813k 11k 914k -637k
Total Cash From Operating Activities 19.51M 14.18M 34.8M 35.1M
Depreciation 4.32M 5.42M 8.39M 11.07M
Change To Account Receivables -1.28M -1.3M -939k -818k
Other Cashflows From Financing Activities -1.2M -2.06M -4.55M -401k
Change To Netincome -6.11M 4.71M 4.32M 7.09M
Capital Expenditures -3.05M -3.76M -2.98M -4.88M

Income Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Research Development 8.2M 9.28M 10.1M 11.8M
Income Before Tax 28.44M 21.68M 27.36M 34.29M
Net Income 22.94M 17.93M 21.22M 26.91M
Selling General Administrative 45.01M 49.39M 46.2M 53.16M
Gross Profit 73.94M 79.85M 84.62M 101.38M
Ebit 20.73M 21.18M 28.32M 36.42M
Operating Income 20.73M 21.18M 28.32M 36.42M
Interest Expense -2k -1.31M -1.31M -2.22M
Income Tax Expense 5.5M 3.75M 6.14M 7.38M
Total Revenue 105.57M 117.23M 129.37M 154.42M
Cost Of Revenue 31.63M 37.38M 44.75M 53.04M
Total Other Income ExpenseNet 7.71M 496k -962k -2.14M
Net Income From Continuing Ops 22.94M 17.93M 21.22M 26.91M
Net Income Applicable To Common Shares 22.94M 17.93M 21.22M 26.91M

Balance Sheet Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Total Liabilities 22.85M 40.2M 80.24M 38.65M
Total Stockholder Equity 130.24M 148.14M 172.57M 254.15M
Other Current Liabilities 5.66M 3.48M 3.17M 1.82M
Total Assets 153.09M 188.34M 252.81M 292.8M
Common Stock 211k 217k 221k 235k
Other Current Assets
Retained Earnings 45.83M 57.03M 70.55M 88.12M
Treasury Stock -14.25M -15.04M -13.13M -15.84M
Cash 26.32M 11.79M 26.76M 13.86M
Total Current Liabilities 19.76M 20.85M 25.14M 21.81M
Other Stockholder Equity -3.9M -4.01M -1.52M -3.44M
Property, Plant, and Equipment 14.1M 30.06M 31.1M 32.13M
Total Current Assets 94.02M 92.09M 94.26M 139.88M
Net Tangible Assets 86.67M 83.3M 47.72M 135.5M
Net Receivables 15.72M 16.57M 19.55M 19.63M
Accounts Payable 1.73M 2.6M 2.39M 2.34M


Insider Transactions

Here are the insider transactions of stock shares related to Lemaitre Vascular Inc:

Filer Name Transaction Text Ownership Date Filer Relation Shares
ROBERTS DAVID BRIANStock Award(Grant) at price 0.00 per share.D2022-11-07President225
LEMAITRE GEORGE WSale at price 52.67 - 54.65 per share.D2022-08-17Chief Executive Officer26.57k
LEMAITRE GEORGE WSale at price 54.75 - 55.89 per share.D2022-08-15Chief Executive Officer58.63k
PELLEGRINO JOSEPH P JRSale at price 53.88 - 54.63 per share.D2022-08-10Chief Financial Officer34.74k
PELLEGRINO JOSEPH P JRConversion of Exercise of derivative security at price 14.13 - 37.29 per share.D2022-08-10Chief Financial Officer32k
KAMKE TRENT GStock Award(Grant) at price 0.00 per share.D2022-08-05Officer187
KAMKE TRENT GSale at price 48.22 per share.D2022-03-02Officer7.93k
KAMKE TRENT GConversion of Exercise of derivative security at price 14.13 - 31.30 per share.D2022-03-02Officer5.59k
ROBERTS DAVID BRIANConversion of Exercise of derivative security at price 14.13 per share.D2022-02-25President7.08k
PELLEGRINO JOSEPH P JRSale at price 52.00 per share.D2021-12-27Chief Financial Officer807
PELLEGRINO JOSEPH P JRConversion of Exercise of derivative security at price 14.13 - 23.56 per share.D2021-12-27Chief Financial Officer807
LEMAITRE GEORGE WConversion of Exercise of derivative security at price 23.56 - 37.29 per share.D2021-12-22Chief Executive Officer40.89k
PELLEGRINO JOSEPH P JRD2021-12-22Chief Financial Officer11
ROBERTS DAVID BRIAND2021-12-22President11
O'CONNOR JOHN JAMES EDWARDStock Gift at price 0.00 per share.D2021-12-22Director9.37k
KAMKE TRENT GD2021-12-20Officer14
LEMAITRE GEORGE WD2021-12-20Chief Executive Officer70
LEMAITRE GEORGE WD2021-12-20Chief Executive Officer70
PELLEGRINO JOSEPH P JRD2021-12-20Chief Financial Officer21
ROBERTS DAVID BRIAND2021-12-20President21
ROUSH JOHN AStock Award(Grant) at price 48.60 per share.D2021-12-10Director576
KAMKE TRENT GStock Award(Grant) at price 48.60 per share.D2021-12-10Officer1.16k
LEMAITRE GEORGE WStock Award(Grant) at price 48.60 per share.D2021-12-10Chief Executive Officer5.66k
PELLEGRINO JOSEPH P JRStock Award(Grant) at price 48.60 per share.D2021-12-10Chief Financial Officer2.57k
JASINSKI LAWRENCE JStock Award(Grant) at price 48.60 per share.D2021-12-10Director576
ROBERTS DAVID BRIANStock Award(Grant) at price 48.60 per share.D2021-12-10President2.57k
ROSS BRIDGET A.Stock Award(Grant) at price 48.60 per share.D2021-12-10Director576
O'CONNOR JOHN JAMES EDWARDStock Award(Grant) at price 48.60 per share.D2021-12-10Director576
KAMKE TRENT GD2021-12-02Officer1
LEMAITRE GEORGE WD2021-12-02Chief Executive Officer7
PELLEGRINO JOSEPH P JRD2021-12-02Chief Financial Officer1
ROBERTS DAVID BRIAND2021-12-02President1
ROBERTS DAVID BRIANSale at price 52.24 per share.D2021-11-03President19.71k
ROBERTS DAVID BRIANConversion of Exercise of derivative security at price 11.43 - 14.13 per share.D2021-11-03President19.71k
KAMKE TRENT GD2021-07-23Officer9
LEMAITRE GEORGE WD2021-07-23Chief Executive Officer116
LEMAITRE GEORGE WD2021-07-23Chief Executive Officer116
PELLEGRINO JOSEPH P JRD2021-07-23Chief Financial Officer39
PELLEGRINO JOSEPH P JRD2021-07-23Chief Financial Officer39
ROBERTS DAVID BRIAND2021-07-23President40
LEMAITRE GEORGE WConversion of Exercise of derivative security at price 14.13 - 15.54 per share.D2021-06-28Chief Executive Officer31.73k
KAMKE TRENT GSale at price 58.00 - 58.01 per share.D2021-06-15Officer3.31k
KAMKE TRENT GConversion of Exercise of derivative security at price 23.56 per share.D2021-06-15Officer3.31k
KAMKE TRENT GSale at price 53.15 - 55.00 per share.D2021-06-10Officer6.62k
KAMKE TRENT GConversion of Exercise of derivative security at price 23.56 - 35.48 per share.D2021-06-10Officer6.62k
LEMAITRE GEORGE WStock Gift at price 0.00 per share.D2021-06-10Chief Executive Officer1.87k
ROUSH JOHN ASale at price 50.00 - 50.25 per share.D2021-05-25Director7.5k
ROUSH JOHN AConversion of Exercise of derivative security at price 14.13 per share.D2021-05-25Director7.5k
LEMAITRE GEORGE WSale at price 48.04 - 48.31 per share.D2021-05-13Chief Executive Officer49.63k
LEMAITRE GEORGE WSale at price 49.87 - 51.27 per share.D2021-05-10Chief Executive Officer93.91k
LEMAITRE GEORGE WSale at price 51.31 - 51.68 per share.D/I2021-05-05Chief Executive Officer81.46k

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to Lemaitre Vascular Inc. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on Lemaitre Vascular Inc

Here is the result of two systematic investment strategies applied to Lemaitre Vascular Inc. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on Lemaitre Vascular Inc

The following chart shows the equity curve of the two systematic investment strategies applied to Lemaitre Vascular Inc:

Lemaitre Vascular Inc automated entries

The systematic investment strategy that buys the first day of the month would give a performance of 58.21% on the backtest period.

Performance at glance

Performance

58.21 %

Latent gain

1332.55 $

Invested capital

2289.25 $

Annualized return

14.06 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on Lemaitre Vascular Inc

This is the result of two momentum investment strategies applied to Lemaitre Vascular Inc. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on Lemaitre Vascular Inc

The following chart shows all the entries opened by the momentum investment system on Lemaitre Vascular Inc:

Lemaitre Vascular Inc momentum entries
  • The first momentum investment strategy would give 68.89% of return on Lemaitre Vascular Inc. That represents 4454.69$ of latent gain with 6466.43$ of employed capital.
  • The second momentum investment strategy would give 63.64% of return on Lemaitre Vascular Inc. That represents 2513.62$ of latent gain with 3949.9$ of employed capital.
Performance at glance (1Q Momentum)

Performance

68.89 %

Latent gain

4454.69 $

Invested capital

6466.43 $

Annualized return

41.01 %
Performance at glance (2Q Momentum)

Performance

63.64 %

Latent gain

2513.62 $

Invested capital

3949.9 $

Annualized return

17.39 %

Momentum equity curve on Lemaitre Vascular Inc

The following chart shows the equity curve of the two momentum strategies applied to Lemaitre Vascular Inc:

Lemaitre Vascular Inc momentum equity

Note: the dividends potentially given by Lemaitre Vascular Inc are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Lemaitre Vascular Inc

The following chart shows the employed capital evolution of the two momentum strategies on Lemaitre Vascular Inc since the beginning:

Lemaitre Vascular Inc

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Buy the dip strategy result on Lemaitre Vascular Inc

Buy the dip entry openings on Lemaitre Vascular Inc

Lemaitre Vascular Inc

The performance achieved by the robo-advisor on Lemaitre Vascular Inc is 87.76%. That represents 442.75$ of latent gain with 504.49$ of employed capital. The following chart shows Lemaitre Vascular Inc stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of Lemaitre Vascular Inc, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

87.76 %

Latent gain

442.75 $

Invested capital

504.49 $

Annualized return

41.01 %

Equity curve of the strategy applied to Lemaitre Vascular Inc

The following chart shows the result of the investment strategy applied to Lemaitre Vascular Inc:

Lemaitre Vascular Inc

Note: the dividends potentially given by Lemaitre Vascular Inc are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Lemaitre Vascular Inc

The following chart shows the employed capital evolution since the beginning of the investment strategy on Lemaitre Vascular Inc:

Lemaitre Vascular Inc

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on Lemaitre Vascular Inc

In this section, I will compare the three previous investment strategies applied to Lemaitre Vascular Inc.

Equity curve comparison on Lemaitre Vascular Inc

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

Lemaitre Vascular Inc investment strategy comparison

Employed capital comparison on Lemaitre Vascular Inc

Lemaitre Vascular Inc investment comparison

Performance comparison on Lemaitre Vascular Inc

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment 58.21% 1332.55$ 2289.25$ 14.06%
Momentum 1 quarter 68.89% 4454.69$ 6466.43$ 17.66%
Momentum 2 quarters 63.64% 2513.62$ 3949.9$ 17.39%
Non-directional 87.76% 442.75$ 504.49$ 41.01%
Annualized return comparison

Automatic investment

14.06 %

Momentum 1Q

17.39 %

Momentum 2Q

17.39 %

Non-directional

41.01 %

Correlated stocks

Here are the most positively and negatively correlated stocks with Lemaitre Vascular Inc:

Note: The algorithm computes the probability of correlation between Lemaitre Vascular Inc and the other stocks. There may be false positives or some missing correlated stocks. If the price of Lemaitre Vascular Inc does not vary for 36 weeks, the correlation calculation result will be wrong.


Company information

Company name Lemaitre Vascular Inc
Country United States
City Burlington
Address 63 Second Avenue
Phone 781 221 2266
Website www.lemaitre.com
FullTime employees 450
Industry Medical Instruments & Supplies
Sector Healthcare
Exchange XNAS
Ticker LMAT
Market www.nasdaq.com

Lemaitre Vascular Inc ESG Scores

Environment scores

Environment ESG Factors Scores
Environment Score 0
Peer Environment Performance unknown
Environment Percentile unknown
Palm Oil unknown
Nuclear unknown
Fur Leather unknown
GMO unknown
Coal unknown
Pesticides unknown
Animal Testing unknown

Social scores

Social ESG Factors Scores
Social Score 0
Peer Social Performance unknown
Social Percentile unknown
Highest Controversy unknown
Peer Highest Controversy Performance unknown
Adult unknown
Gambling unknown
Alcoholic unknown
Tobacco unknown
Catholic unknown
Controversial Weapons unknown
Small Arms unknown
Military Contract unknown
Peer Count unknown

Related Controversy:


Governance scores

Governance ESG Factors Scores
Governance Score 0
Peer Governance Performance unknown
Governance Percentile unknown

ESG at glance
Total ESG Scores: unknown
Environment Score: 0
Social Score: 0
Governance Score: 0

ESG Performance: unknown

Peer Group: unknown

Peer Esg Score Performance: unknown

Rating Year: unknown

Rating Month: unknown

Max Age: unknown

Percentile: unknown